4.6 Review

Protein Interaction Domains: Structural Features and Drug Discovery Applications (Part 2)

期刊

CURRENT MEDICINAL CHEMISTRY
卷 28, 期 5, 页码 854-892

出版社

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/0929867327666200114114142

关键词

Protein interaction domains; protein-protein interactions; structure; drug discovery; ligands; inhibitors; peptides; small molecules

资金

  1. Fondazione Umberto Veronesi

向作者/读者索取更多资源

This study focuses on Protein Interaction Domains (PIDs) that can recognize post-translationally modified peptide segments and those that interact with simple peptide sequences composed of standard amino acids. PIDs are versatile in structure and function, playing important roles in signal transduction and disease pathways, making them potential therapeutic targets for drug discovery.
Background: Proteins present a modular organization made up of several domains. Apart from the domains playing catalytic functions, many others are crucial to recruit interactors. The latter domains can be defined as PIDs (Protein Interaction Domains) and are responsible for pivotal outcomes in signal transduction and a certain array of normal physiological and disease-related pathways. Targeting such PIDs with small molecules and peptides able to modulate their interaction networks, may represent a valuable route to discover novel therapeutics. Objective: This work represents a continuation of a very recent review describing PIDs able to recognize post-translationally modified peptide segments. On the contrary, the second part concerns with PIDs that interact with simple peptide sequences provided with standard amino acids. Methods: Crucial structural information on different domain subfamilies and their interactomes was gained by a wide search in different online available databases (including the PDB (Protein Data Bank), the Pfam (Protein family), and the SMART (Simple Modular Architecture Research Tool)). Pubmed was also searched to explore the most recent literature related to the topic. Results and Conclusion: PIDs are multifaceted: they have all diverse structural features and can recognize several consensus sequences. PIDs can be linked to different diseases onset and progression, like cancer or viral infections and find applications in the personalized medicine field. Many efforts have been centered on peptide/peptidomimetic inhibitors of PIDs mediated interactions but much more work needs to be conducted to improve drug-likeness and interaction affinities of identified compounds.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据